Federal Register of Legislation - Australian Government

Primary content

PB 65 of 2014 Determinations/Health as made
This determination amends the National Health Act 1953 - Determination under section 84AH - Exempt items (No. PB 58 of 2007) where one specified form of the drug clarithromycin is to be an exempt item.
Administered by: Health
Made 25 Aug 2014
Registered 29 Aug 2014
Tabled HR 02 Sep 2014
Tabled Senate 02 Sep 2014
Date of repeal 02 Sep 2014
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003

 

PB 65 of 2014

Amendment Determination under section 84AH of the National Health Act 1953 (2014) (No. 3)

 

National Health Act 1953

___________________________________________________________________________

 

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the
Minister for Health, make this instrument under section 84AH of the
National Health Act 1953.

Dated                   25            August 2014

 

 

 

 

 

 

 

 

 

 

 

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

___________________________________________________________________

 

 

 

 

 

1              Name of Instrument

 

(1)                This Instrument is the Amendment Determination under section 84AH of the National Health Act 1953 (2014) (No. 3).

 

(2)                This Instrument may also be cited as PB 65 of 2014.

 

2              Commencement

                            This Instrument commences on 1 September 2014.

3              Amendments to PB 58 of 2007

                      Schedule 1 amends the legislative instrument titled Determination under section 84AH of the National Health Act 1953 (PB 58 of 2007) (as amended).

.

 


Schedule 1                   Amendments

 

      

 

[1]   Schedule 1, after entry for Ciprofloxacin Ear drops 3 mg (as hydrochloride) per mL, 5 mL :

 

                        insert:

 

Clarithromycin

Powder for oral liquid 250 mg per 5 mL, 50 mL

Oral